PSK1 COST EFFECTIVENESS OF THE USE OF INFLIXIMAB COMPARED TO OTHER BIOLOGICAL AGENTS (BA) IN THE SYSTEMIC TREATMENT OF MODERATE TO SEVERE PSORIASIS
May 1, 2007, 00:00
10.1016/S1098-3015(10)68838-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)68838-9/fulltext
Title :
PSK1 COST EFFECTIVENESS OF THE USE OF INFLIXIMAB COMPARED TO OTHER BIOLOGICAL AGENTS (BA) IN THE SYSTEMIC TREATMENT OF MODERATE TO SEVERE PSORIASIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68838-9&doi=10.1016/S1098-3015(10)68838-9
First page :
Section Title :
Open access? :
No
Section Order :
627